All In MedTech

Device Trial Radar · NCT01700114

Post-Approval Study of MelaFind

Last checked: Nov 20, 2026Latest source record: Mar 11, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

487

Actual

Start

Nov 2012

Primary completion

Jan 2016

Study completion Jan 2016

Sponsor

Lead sponsor
MELA Sciences, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Oct 4, 2012

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to collect data to describe the real-world use and safety and effectiveness of MelaFind® in a post-approval clinical setting.

Conditions

  • Melanoma

Interventions

  • MelaFindDevice

    The device is used when a dermatologist chooses to obtain additional information on atypical skin lesions for a decision to biopsy.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Relative sensitivity comparing enrolling dermatologists after MelaFind use with enrolling dermatoligsts if MelaFind were not availableTime frame: 6 years

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • AboutSkin Dermatology and DermSurgery

    Englewood, Colorado

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.